Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: PepTools vendor-neutral scientific reference catalog
Also known as: desoxycholic acid, choleic acid, dihydroxycholanoic acid, deoxycholate, 3alpha,12alpha-dihydroxy-5beta-cholan-24-oic acid
Deoxycholic acid is a bile acid formed by bacterial conversion of cholate. It is usually conjugated with glycine or taurine, acts as a detergent to solubilize dietary fats for intestinal absorption, and is reabsorbed through enterohepatic circulation. The parent compound is classified as a C24 steroid, dihydroxy-5beta-cholanic acid, and bile acid. In the FDA-approved subcutaneous formulation KYBELLA, deoxycholic acid functions as a cytolytic agent by disrupting cell membranes.
Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Reference information combines identity and chemical-property records with biological classification and FDA-labeled formulation data. FDA dose, timing, route, and pharmacokinetic details are formulation-specific research/reference data for KYBELLA and should not be generalized to other preparations or uses. Common reference package sizes are not treated as an intrinsic scientific property of the compound and are therefore omitted.
Supplementary research context only. Not medical advice or a treatment recommendation.
CAS RN 83-44-3; molecular formula C24H40O4; molecular weight 392.57 g/mol; PubChem CID 222528; ChEBI CHEBI:28834; HMDB HMDB0000626; FDA UNII 005990WHZZ; InChIKey KXGVEGMKQFWNSR-LLQZFEROSA-N
Deoxycholic acid is an endogenous bile-acid constituent. Most endogenous deoxycholic acid is sequestered in the enterohepatic circulation. Following subcutaneous administration of the approved 100 mg KYBELLA treatment, plasma concentrations returned to the endogenous range within 24 hours; the FDA label does not provide a conventional terminal half-life.
Reflects published research. Educational reference — not a recommendation for use.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention deoxycholic acid or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.